Robbie Gerome Majzner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunotherapy, Adoptive | 27 | 2024 | 1393 | 3.760 |
Why?
|
| Gangliosides | 5 | 2022 | 131 | 2.050 |
Why?
|
| Receptors, Antigen, T-Cell | 13 | 2024 | 2511 | 2.020 |
Why?
|
| Neuroblastoma | 6 | 2022 | 1232 | 1.250 |
Why?
|
| T-Lymphocytes | 19 | 2024 | 10018 | 1.190 |
Why?
|
| Antigens, Neoplasm | 5 | 2023 | 1973 | 0.960 |
Why?
|
| Logic | 1 | 2023 | 41 | 0.870 |
Why?
|
| Antigens, CD19 | 6 | 2022 | 410 | 0.740 |
Why?
|
| Brain Stem Neoplasms | 1 | 2022 | 191 | 0.690 |
Why?
|
| Neoplasms | 16 | 2024 | 21688 | 0.660 |
Why?
|
| Astrocytoma | 1 | 2022 | 775 | 0.580 |
Why?
|
| Bone Neoplasms | 4 | 2022 | 2495 | 0.570 |
Why?
|
| Immunotherapy | 10 | 2023 | 4594 | 0.510 |
Why?
|
| Osteosarcoma | 4 | 2022 | 875 | 0.480 |
Why?
|
| Histones | 2 | 2022 | 2552 | 0.460 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2021 | 221 | 0.430 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1061 | 0.390 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 2198 | 0.370 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 1800 | 0.370 |
Why?
|
| Ferrosoferric Oxide | 2 | 2022 | 348 | 0.360 |
Why?
|
| Glioma | 2 | 2022 | 3373 | 0.340 |
Why?
|
| Bone Marrow Transplantation | 1 | 2017 | 2676 | 0.320 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 4617 | 0.310 |
Why?
|
| Tissue Donors | 1 | 2017 | 2206 | 0.290 |
Why?
|
| Cell Line, Tumor | 12 | 2024 | 16657 | 0.260 |
Why?
|
| Lymphoma, B-Cell | 2 | 2023 | 925 | 0.260 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3607 | 0.250 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2021 | 3526 | 0.240 |
Why?
|
| Cancer Vaccines | 2 | 2023 | 1044 | 0.230 |
Why?
|
| Macrophages | 2 | 2024 | 5652 | 0.230 |
Why?
|
| Signal Transduction | 4 | 2023 | 23112 | 0.230 |
Why?
|
| Tumor Microenvironment | 5 | 2024 | 3694 | 0.220 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 8832 | 0.220 |
Why?
|
| Cyclin C | 1 | 2022 | 12 | 0.220 |
Why?
|
| Herpesvirus 6, Human | 1 | 2023 | 95 | 0.220 |
Why?
|
| Leukemia, B-Cell | 1 | 2023 | 83 | 0.210 |
Why?
|
| Mediator Complex | 1 | 2022 | 107 | 0.200 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2022 | 116 | 0.200 |
Why?
|
| Glypicans | 1 | 2021 | 34 | 0.200 |
Why?
|
| Virus Activation | 1 | 2023 | 316 | 0.200 |
Why?
|
| Virus Latency | 1 | 2023 | 364 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2021 | 3722 | 0.180 |
Why?
|
| Leukapheresis | 1 | 2020 | 129 | 0.180 |
Why?
|
| Thymidine Kinase | 1 | 2020 | 283 | 0.180 |
Why?
|
| Mutation | 2 | 2022 | 29614 | 0.170 |
Why?
|
| Neoplasms, Experimental | 2 | 2022 | 1229 | 0.170 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2022 | 265 | 0.170 |
Why?
|
| Receptors, IgE | 1 | 2021 | 381 | 0.170 |
Why?
|
| Mice | 15 | 2024 | 80087 | 0.170 |
Why?
|
| Furans | 1 | 2020 | 192 | 0.170 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2023 | 294 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2019 | 284 | 0.160 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2018 | 87 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 419 | 0.160 |
Why?
|
| Luciferases | 1 | 2020 | 716 | 0.160 |
Why?
|
| Luminescent Measurements | 1 | 2020 | 374 | 0.160 |
Why?
|
| Humans | 41 | 2024 | 746044 | 0.160 |
Why?
|
| Child | 13 | 2024 | 78456 | 0.150 |
Why?
|
| Receptors, Immunologic | 2 | 2024 | 1415 | 0.150 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 205 | 0.150 |
Why?
|
| Animals | 19 | 2024 | 166331 | 0.150 |
Why?
|
| Luminescent Proteins | 1 | 2020 | 834 | 0.150 |
Why?
|
| Teratoma | 1 | 2020 | 397 | 0.140 |
Why?
|
| Receptors, Antigen | 1 | 2017 | 51 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2022 | 9170 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2020 | 1531 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 4 | 2022 | 9105 | 0.130 |
Why?
|
| Gadolinium | 1 | 2021 | 945 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2022 | 1523 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 551 | 0.130 |
Why?
|
| Burkitt Lymphoma | 1 | 2017 | 325 | 0.120 |
Why?
|
| Leukemia | 1 | 2023 | 1499 | 0.120 |
Why?
|
| Antibodies, Bispecific | 1 | 2017 | 180 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 11036 | 0.120 |
Why?
|
| Rhabdomyosarcoma | 1 | 2017 | 357 | 0.120 |
Why?
|
| Epigenesis, Genetic | 3 | 2021 | 3655 | 0.110 |
Why?
|
| Lysine | 1 | 2018 | 987 | 0.110 |
Why?
|
| Cerebellar Neoplasms | 1 | 2018 | 584 | 0.110 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2017 | 532 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2018 | 675 | 0.110 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1394 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2018 | 930 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 1651 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 4296 | 0.090 |
Why?
|
| Lymphocyte Transfusion | 1 | 2012 | 223 | 0.090 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2012 | 252 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 1793 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2022 | 1916 | 0.090 |
Why?
|
| Lymphocyte Depletion | 1 | 2012 | 588 | 0.090 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 630 | 0.090 |
Why?
|
| Clinical Trials as Topic | 3 | 2023 | 7935 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1638 | 0.090 |
Why?
|
| Injections, Intraventricular | 2 | 2020 | 224 | 0.080 |
Why?
|
| Receptor, erbB-2 | 1 | 2018 | 2466 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 2820 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 6508 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9310 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 3538 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 17834 | 0.060 |
Why?
|
| Lymphocyte Activation | 3 | 2021 | 5413 | 0.060 |
Why?
|
| Risk | 1 | 2017 | 9520 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4056 | 0.060 |
Why?
|
| Roseolovirus Infections | 1 | 2023 | 48 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2022 | 48 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2017 | 3453 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2019 | 63661 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18146 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2022 | 41376 | 0.050 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2022 | 148 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2023 | 437 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2024 | 846 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2024 | 547 | 0.050 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2021 | 83 | 0.050 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2020 | 35 | 0.050 |
Why?
|
| High Mobility Group Proteins | 1 | 2021 | 171 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 164 | 0.040 |
Why?
|
| Motion | 1 | 2024 | 781 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2020 | 253 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2023 | 944 | 0.040 |
Why?
|
| Enzyme Assays | 1 | 2020 | 108 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 2012 | 2931 | 0.040 |
Why?
|
| Protein Stability | 1 | 2021 | 563 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2022 | 658 | 0.040 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 618 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2022 | 1028 | 0.040 |
Why?
|
| Infant | 2 | 2020 | 35444 | 0.040 |
Why?
|
| Microscopy | 1 | 2024 | 878 | 0.040 |
Why?
|
| Incidence | 1 | 2017 | 20812 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2022 | 1978 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 2020 | 413 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2019 | 318 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 35784 | 0.040 |
Why?
|
| Adult | 7 | 2024 | 214958 | 0.040 |
Why?
|
| Adolescent | 4 | 2024 | 86202 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2020 | 690 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2021 | 1340 | 0.040 |
Why?
|
| Gene Order | 1 | 2017 | 170 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 57106 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2021 | 2288 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2021 | 7571 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2020 | 1779 | 0.030 |
Why?
|
| Antibodies | 1 | 2024 | 2406 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1809 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 23453 | 0.030 |
Why?
|
| Methylation | 1 | 2018 | 1075 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2020 | 748 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 2620 | 0.030 |
Why?
|
| Viral Load | 1 | 2023 | 3297 | 0.030 |
Why?
|
| Lentivirus | 1 | 2017 | 495 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2021 | 1331 | 0.030 |
Why?
|
| Disease Progression | 2 | 2021 | 13303 | 0.030 |
Why?
|
| Male | 7 | 2024 | 351093 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2021 | 2905 | 0.030 |
Why?
|
| Ligands | 1 | 2020 | 3266 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2020 | 1800 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2022 | 1567 | 0.030 |
Why?
|
| Female | 7 | 2024 | 382109 | 0.030 |
Why?
|
| Fetus | 1 | 2020 | 1882 | 0.030 |
Why?
|
| Remission Induction | 1 | 2017 | 2361 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2018 | 2326 | 0.020 |
Why?
|
| United States | 1 | 2019 | 70383 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4178 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3742 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2012 | 695 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2022 | 3477 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2020 | 8294 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8373 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3475 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2500 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 164236 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5162 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3012 | 0.020 |
Why?
|
| Contrast Media | 1 | 2021 | 5253 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5694 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2017 | 3346 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 214412 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9278 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9441 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5607 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 7580 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2020 | 18891 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12202 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10592 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12039 | 0.010 |
Why?
|
| Cytokines | 1 | 2017 | 7219 | 0.010 |
Why?
|
| Pediatrics | 1 | 2018 | 3559 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9421 | 0.010 |
Why?
|
| Models, Biological | 1 | 2018 | 9443 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 11839 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 6781 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12632 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13538 | 0.010 |
Why?
|
| Brain | 1 | 2020 | 26596 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 53218 | 0.000 |
Why?
|